MAPT and Alzheimer disease: Furthermore, in an okadaic acid-induced tauopathy model of AD, there was reduced neuroinflammation, as shown by reduced TNF levels in the brain, and reduced neuronal death when treated with Tau-nChap, possibly due to a reduction in tau NFTs [41].